AzTrials
AzTrials

Accidental FallNCT07891637

Effects of a Novel Perturbation Balance Training Program on Laboratory and Real-World Trip-Induced Losses of Balance and Falls Among Balance-Impaired Older Adults

A study testing Step Training, Treadmill Training and Otago Exercise Program in people with Accidental Fall, run by Virginia Polytechnic Institute and State University at 2 sites in United States.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this clinical trial is to learn if a novel balance training stepping exercise can reduce the risk of falling among adults over the age of 65. The main question it aims to answer is: Does the novel stepping exercise improve laboratory-based measurements of balance and fall rate? Does the novel stepping… Read more about this study

Who is it for?
Ages 65 years and olderHealthy volunteers can take part
Conditions the study is for
Accidental Fall
What is being tested?
Step Training, Treadmill Training and Otago Exercise Program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
180 participants
Where
2 sitesUnited States
Study dates
Jan 2027to Aug 2031
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • Healthy volunteers accepted
  • Older adult

Who may be able to join

  • Age ≥ 65 years
  • Moderate balance impairment as indicated by best unipedal stance time <10 seconds
  • Able to ambulate household distances and tolerate testing and training without an assistive device
  • No significant cognitive impairment (telephone Montreal Cognitive Assessment >18)
  • Functional vision and hearing (with correction if needed)
  • Comprehension of written and spoken English
Show all 10Show fewer
  • Willing and able to study-required voice recorders
  • Limited physical activity (<150 min/week moderate-vigorous), not in physical therapy, not presently in balance training programs (such as Tai Chi training).
  • Not having acute or chronic conditions which would significantly alter study participation and markedly bias the results: active or symptomatic cardiopulmonary conditions; active or unstable metabolic conditions such as labile glycemic control; alcohol intake >3 oz/day; hemiplegia or lower limb amputation; acute medical conditions, such as acute flare-up of joint condition or infection; significant orthopedic or musculoskeletal condition that does not allow weight bearing.
  • Osteoporosis screening (only for subjects exposed to lab-induced trip): bone mineral density t-score > -2.5 and no history of fragility fracture of the hip, spine, or wrist.

Who cannot join

None listed.

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Michael Madigan, PhD contact

1-540-231-6656

mlm@vt.edu

United States2 sites
  • University of Michigan

    Ann Arbor, Michigan, 48109

    Neil Alexander, MD, 17347646831, nalexand@med.umich.edu

  • Virginia Tech

    Blacksburg, Virginia, 24061

    Michael Madigan, PhD, 15402316656, mlm@vt.edu

Other trials in United States

About this study

The goal of this clinical trial is to learn if a novel balance training stepping exercise can reduce the risk of falling among adults over the age of 65. The main question it aims to answer is:

  • Does the novel stepping exercise improve laboratory-based measurements of balance and fall rate?
  • Does the novel stepping exercise improve real-world measurements of balance and fall rate?
Read more

Researchers will compare the novel stepping exercise to 1) a more established stepping exercise that requires more expensive equipment, and 2) a more established general exercise program focusing on strength and standing balance without stepping.

Participants will:

  • complete their assigned exercise intervention twice a week for three weeks, then complete booster sessions of their assigned exercise intervention once a month during months 1-5 after completing the initial three weeks of intervention
  • complete laboratory sessions to test their balance: a) before intervention, b) 1 week after intervention, and c) 6 months after intervention
  • use a wearable sensor daily for 12 months after intervention to capture any loss of balance or fall events
Conditions
Accidental Fall
Being tested
Step Training, Treadmill Training, Otago Exercise Program
Keywords
balance training, older adults, wearable sensors, fall prevention, exercise, step training
Medical subject headings
Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Step TrainingBehavioural

    Perturbation-based balance training without a treadmill. Initial dosage will be twice a week for three weeks. Then booster sessions will be completed once a month during months 1-5 after completing the initial three weeks of intervention.

  • Treadmill TrainingBehavioural

    Perturbation-based balance training with a treadmill. Initial dosage will be twice a week for three weeks. Then booster sessions will be completed once a month during months 1-5 after completing the initial three weeks of intervention.

  • Otago Exercise ProgramBehavioural

    Strength and standing balance training without stepping. Initial dosage will be twice a week for three weeks. Then booster sessions will be completed once a month during months 1-5 after completing the initial three weeks of intervention.

Study groups in NCT07891637
Study groupRoleWhat they receive
Step TrainingExperimentalPerturbation-based balance training without a treadmill
Receives: Behavioral: Step Training
Treadmill TrainingExperimentalPerturbation-based balance training with a treadmill
Receives: Behavioral: Treadmill Training
Otago Exercise ProgramActive comparatorStrength and standing balance training.
Receives: Behavioral: Otago Exercise Program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Trunk angle during balance recovery after lab-induced trip

    Angle from vertical to a line connecting midpoint of greater trochanter markers and midpoint of acromion markers, measured at the instant of touchdown of the first step over the trip obstacle.

    This outcome measure will only be obtained from the n=60 subjects at Virginia Tech.

    Measured: Before intervention, 1-week after intervention, and 6-months after intervention.

  2. Recovery step length after lab-induced trip

    The distance between a lateral malleolus marker of the stance limb and a lateral malleolus marker of the stepping limb after the first step over the tripping obstacle.

    This outcome measure will only be obtained from the n=60 subjects at Virginia Tech.

    Measured: Before intervention, 1-week after intervention, and 6-months after intervention.

  3. Recovery step speed after lab-induced trip

    Step length divided by step time. Step length is the distance between a lateral malleolus marker of the stance limb and a lateral malleolus marker of the stepping limb after the first step over the tripping obstacle. Step time is the time from the foot first contacting the trip obstacle and the first step over the trip obstacle contacting the floor.

    This outcome measure will only be obtained from the n=60 subjects at Virginia Tech.

    Measured: Before intervention, 1-week after intervention, and 6-months after intervention.

  4. Fall rate after lab-induced trip

    Number of falls into a safety harness divided by the total number of trips.

    This outcome measure will only be obtained from the n=60 subjects at Virginia Tech.

    Measured: Before intervention, 1-week after intervention, 6-months after intervention.

  5. Number of real-world losses of balance during 12-month follow up

    This outcome measure will be obtained from the n=180 subjects across both sites at Virginia Tech and University of Michigan.

    Measured: From the end of intervention until 12 months later.

  6. Number of real-world balance recoveries during 12-month follow up

    This outcome measure will be obtained from the n=180 subjects across both sites at Virginia Tech and University of Michigan.

    Measured: From the end of intervention until 12 months later

  7. Number of real-world falls during 12-month follow up

    This outcome measure will be obtained from the n=180 subjects across both sites at Virginia Tech and University of Michigan.

    Measured: From the end of intervention until 12 months later

Secondary outcomes (3)
  1. Short Portable Performance Battery

    A standardized clinical mobility test involving gait speed, standing balance, and chair rises.

    This outcome measure will be obtained from the n=180 subjects across both sites at Virginia Tech and University of Michigan.

    Measured: Before intervention, 1-week after intervention, and 6-months after intervention.

  2. Berg Balance Scale

    A standardized clinical mobility test involving multiple balance components and an overall composite score that can predict falls.

    This outcome measure will be obtained from the n=180 subjects across both sites at Virginia Tech and University of Michigan.

    Measured: Before intervention, 1-week after intervention, and 6-months after intervention.

  3. Activities Balance Confidence Scale

    A standardized questionnaire that involves subjects rating their confidence to avoid falls while doing common activities. This outcome measure will be obtained from the n=180 subjects across both sites at Virginia Tech and University of Michigan.

    Measured: Before intervention, 1-week after intervention, and 6-months after intervention.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Oct 2026
  2. Study startJan 2027 (estimated)
  3. Primary completionDec 2030 (estimated)
  4. Study completionAug 2031 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
180 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07891637
Sponsor's protocol ID
26-766
Other IDs
1R01AG097954
Status last verified
Oct 2026
First submitted
16 Oct 2026
Last updated
23 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The data from balance testing pre-intervention, 1-week after intervention, and 6-months after intervention will include fall rate and body motion measurements in response to a laboratory-induced trip, and clinical mobility assessments. These will be saved as comma-delimited text files. During the 12-month follow up, voice recorder data will be obtained to count losses of balance, balance recoveries, falls, and contextual information of these events. These will be transcribed and saved as MS Word documents.

Questions about this trial

What is this clinical trial studying?

A study testing Step Training, Treadmill Training and Otago Exercise Program in people with Accidental Fall, run by Virginia Polytechnic Institute and State University at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 23 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Michael Madigan, PhD (1-540-231-6656, mlm@vt.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Trunk angle during balance recovery after lab-induced trip (time frame: Before intervention, 1-week after intervention, and 6-months after intervention.). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in